Status:
COMPLETED
Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare whether Symbicort Maintenance \& Reliever Therapy (SMART) is more effective in uncontrolled asthmatic patients than their current therapy in a real life situati...
Eligibility Criteria
Inclusion
- Provision of signed informed consent
- Asthma diagnosis at least 6 months before visit 1 of study
- Patients who have reversible airway obstruction continuous asthma treatment except Symbicort at least within 4 weeks before visit 1 of study
Exclusion
- Known or suspected allergy to active ingredients of study medication or excipients
- Use of oral, rectal or parenteral glucocorticosteroids 30 days before visit 1 of study
- Smoking, current or previous with a smoking history of ≥ 10 pack years
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
862 Patients enrolled
Trial Details
Trial ID
NCT00939341
Start Date
July 1 2009
End Date
August 1 2010
Last Update
January 16 2012
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Guangzhou, Guangdong, China
2
Research Site
Zheng Ahou, Henan, China
3
Research Site
Wuhan, Hubei, China
4
Research Site
Changsha, Hunan, China